Translational Research Center in Lung Cancer Disparities (TRACER) Project 2 (TRACER)

October 20, 2026 updated by: Virginia Commonwealth University

Biological Pathways in Stress Reactivity and Nicotine Addiction Among African American and White Smokers

The purpose of this study is to examine racial differences in smoking behaviors and stress responses between African American and white male smokers.

Study Overview

Detailed Description

Cigarette smoking is a leading cause of morbidity and mortality from lung cancer among adults in the US. Stress relief and smoking cessation is the best preventive strategy for reducing lung cancer risk and addressing racial disparities in outcomes. Despite this, racial differences are found among those that make quit attempts. Stress has been found to be related to smoking initiation, maintenance, and relapse. Yet, differences in stress responses have not been examined between African American and white smokers. Therefore, this study will examine racial differences in stress responses and smoking behaviors between African American and white male smokers

Study Type

Observational

Enrollment (Actual)

92

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90089
        • University of Southern California
    • South Carolina
      • Charleston, South Carolina, United States, 29425
        • Medical University of South Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

African American and white male daily smokers who are between the ages of 18-75 and who smoke at least 5 to 10 cigarettes per day.

Description

Inclusion Criteria:

  • African American and white males
  • Between the ages of 18-75 years old
  • Smoke at least 5 to 10 cigarettes per day

Exclusion Criteria:

  • Smokers who have a serious cognitive disorder
  • Have a personal history of lung cancer
  • Personal history of usage of illicit drug and alcohol abuse
  • Enrollment in a smoking cessation treatment program during the past 6 months
  • Current use of a nicotine replacement therapy
  • Have any positive responses on the Mini International Neuropsychiatric Interview (MINI) screener

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Baseline Health survey and Trier Social Stress Test (TSST) African American Men

African American male smokers

Baseline Health survey and Trier Social Stress Test (TSST) White Men

White male smokers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Examining Racial Differences in Cortisol During TSST Which Activates Acute Stress Responses
Time Frame: 90-minute laboratory stress test, scheduled after completion of baseline health survey

Examine racial differences in acute stress responses using a validated psychological stress challenge called the Trier Social Stress Test (TSST). This aim will examine racial disparities in cortisol responses to an acute stressor among AA/Black and white male smokers in a laboratory setting. Changes in cortisol levels will be the primary outcome variable and will be measured multiple times during the course of the TSST. To examine the effects of race on acute stress responses to the TSST laboratory stressors the response area under the curve (rAUC) for cortisol will be calculated using trapezoidal approximation with the samples obtained at time zero (T0) to the last measurement (T24m).

90-minute laboratory stress test, scheduled after completion of baseline health survey
Examining Changes in Daily Cortisol Patterns According to Race for Those Who Completed TSST.
Time Frame: 4- week and 8-week at-home post-TSST home post TSST daily saliva (cortisol) data collection

Examine racial differences in daily diurnal cortisol slopes to evaluate hypothalamic-pituitary-adrenal-axis dysregulation and acute stress. A higher score means a flatter slope, and reflects higher chronic stress. No scale for slope.

4- week and 8-week at-home post-TSST home post TSST daily saliva (cortisol) data collection
Examine the Relationship Between Perceived Stress and Smoking Behavior Across Groups
Time Frame: Baseline health survey pre-TSST

Assessed perceived stress using the 4-item Perceived Stress Scale (PSS-4), a validated self-report measure of how stressful an individual's life situations are perceived to be. Participants rate each item on a 5-point scale from 0 (never) to 4 (very often). Positively worded items are reverse-scored, and the four items are summed to produce a total score ranging from 0 to 16. Higher scores indicate greater perceived stress. Stress is compared for those who reported at least 1 quit attempt within the past 12 months and for those who did not.

Baseline health survey pre-TSST

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vanessa Sheppard, PhD, Virginia Commonwealth University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2024

Primary Completion (Actual)

August 31, 2025

Study Completion (Actual)

August 31, 2025

Study Registration Dates

First Submitted

May 5, 2022

First Submitted That Met QC Criteria

August 3, 2022

First Posted (Actual)

August 5, 2022

Study Record Updates

Last Update Posted (Actual)

November 12, 2026

Last Update Submitted That Met QC Criteria

October 20, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • MCC-21-18891
  • 00116801 (Other Identifier: Medical University of South Carolina)
  • HM20022956 (Other Identifier: Virginia Commonwealth University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe